Embecta Corp. (EMBC)
Surgical & Medical Instruments & Apparatus · Healthcare · $183M
Intrinsic Value (Consensus)
$0.00
Current Price
$3.09
Margin of Safety
0%
At Fair Value
Value: $0
Price: $3
Valuation Model Estimates
Current Price: $3.09
DCF (Discounted Cash Flow)
$27.04
Graham Number
Not applicable
—
Earnings Power Value
$20.12
Relative Value (P/E)
$37.92
Dividend Discount Model
$6.78
Consensus Value
$0.00
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
44
Profitability
10/25
Strength
18/25
Valuation
12/25
Growth
4/25
Financial Health Signals
Declining revenue — top line is shrinking
High free cash flow yield (99.5%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $1.90
- EPS (Forward)
- $1.99
- Book Value
- $-10.97
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- -3.8%
- Earnings Growth
- 5.0%
- Dividend Yield
- 0.9%
- Beta
- 0.85
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance